BioSpace News Archive

Pharm Country

Rebranded Pfizer Logo Highlights Mission to Cure and Prevent Disease

Pfizer is giving itself a corporate facelift, dropping its traditional blue-pill company logo in favor of a double helix DNA spiral that reflects the advances in medical science that have placed the curing of multiple diseases within reach.

January 6, 2021
·
2 min read
·
Alex Keown
Drug Development

Virologists Voice Growing Concern Over South African COVID-19 Variant

SARS-CoV-2 has mutated into several strains. Most of them are not particularly different than the primary strains, but two, B.1.1.7, which was first observed in the U.K., and now 501.V2, which originated in South Africa, have virologists watching closely.

January 6, 2021
·
3 min read
·
Mark Terry
Genetown

Glympse Advances BioSensors for NASH and Other Protease-Mediated Diseases

Glympse Bio’s tunable biosensors are poised to be a game-changing diagnostic tool in 2021.

January 6, 2021
·
4 min read
·
Gail Dutton
Business

Ribometrix and Genentech Partner in Potential $1 Billion+ RNA Deal

Durham, North Carolina-based Ribometrix announced a strategic collaboration deal with Genentech to identify and advance novel RNA-targeted small molecule therapeutics.

January 6, 2021
·
2 min read
·
Mark Terry
Biotech Bay

Backed by Bayer, Senti Biosciences Snags $105 Million in Series B Fundraising

Backed by Leaps by Bayer, Bay Area-based Senti Biosciences secured $105 million in a Series B financing round that will help the company advance its therapeutic pipeline of allogeneic chimeric antigen receptor natural killer (CAR-NK) cell therapies.

January 6, 2021
·
2 min read
·
Alex Keown
BioSpace Global Roundup: Ayala Moves Forward with Desmoid Tumor Asset in Phase II/III Study

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business.

January 6, 2021
·
6 min read
·
Alex Keown
Drug Development

Research Consortium to Study If COVID-19 Increases Long-Term Risk of Dementia

In a recent paper published in Alzheimer’s and Dementia, a team of researchers is calling for more prospective studies that will look into the impact coronavirus disease 2019 (COVID-19) has on brain functioning.

January 6, 2021
·
2 min read
·
Brandon May
Business

Autolus Aligns Pipeline Around Promising CAR T Cell Therapy Candidate

The recalibration will also have workforce implications, including an overall workforce reduction of approximately 20% during Q1, 2021.

January 6, 2021
·
2 min read
·
Heather McKenzie
Genetown

Rush University Medical Center Expands Deployment of Nuance Dragon Ambient eXperience to 14 Clinical Specialties

Leading academic health center aims to improve the care experience and reduce physician burnout after a successful pilot found Nuance DAX cuts time spent on clinical documentation by more than half

January 6, 2021
·
4 min read
Theralink® Technologies Issues Letter to Shareholders

Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”) , a molecular profiling company specializing in patented, biomarker assay services that target multiple areas of oncology, today issued a letter to shareholders from it

January 6, 2021
·
7 min read